Pseudomonas Aeruginosa Carriage, Colonization, and Infection in ICU Patients

Overview

Journal Intensive Care Med

Specialty Critical Care

Date 2007 May 16

PMID 17503016

Citations 44

Authors

Antonella Agodi

Martina Barchitta

Rosalba Cipresso

Loredana Giaquinta

Maria Antonietta Romeo

Carmelo Denaro

Affiliations

Soon will be listed here.

Abstract

Objective: We evaluated whether Pseudomonas aeruginosa associated nosocomial infections in our ICU originate mainly from patients' endogenous flora or from exogenous cross-transmission.

Design And Setting: A 6-month prospective surveillance survey was performed according to standardized protocols at the interdisciplinary ICU of the Azienda Ospedaliera Cannizzaro.

Patients: The study analyzed 121 patients and focused on three different states: carriage upon admission, colonization of sterile sites, and infections during ICU stay.

Results: We identified 138 P. aeruginosa isolates from 45 patients. The cumulative incidence of P. aeruginosa sustained colonization in the ICU was 29.9/100 patients, and the incidence density was 16.2/1,000 patient-days. The cumulative incidence of P. aeruginosa-sustained infections in the ICU was 36.7/100 patients, and the incidence density was 19.9/1,000 patient-days. The most frequent infection type was ventilator-associated pneumonia. PFGE analysis of P. aeruginosa isolates led to the identification of a major clone represented by 60.8% of isolates involving 45.9% of patients. The impact of cross-transmission, i.e., the preventable proportion of P. aeruginosa acquisition, was estimated to be at least 59.5% of all colonization or infection episodes. Acquisition of multidrug-resistant P. aeruginosa was significantly associated with cross-transmission.

Conclusions: Our results suggest that the ICU personnel and environment served as reservoirs for cross-transmission and emphasize the importance of exogenous acquisition of multidrug-resistant P. aeruginosa, of reduction in antibiotic pressure, and prompt enforcement of infection control measures.

Citing Articles

Molecular Typing of Isolates Collected in Abidjan Hospitals (Côte d'Ivoire) Using the Multiple-Locus Variable Number of Tandem Repeats Method.

Essoh C, Hauck Y, Ouassa T, Toure D, Djatchi R, Loukou G Diagnostics (Basel). 2024; 14(20).

PMID: 39451606 PMC: 11506784. DOI: 10.3390/diagnostics14202284.

Molecular Typing and Resistance Profile of Isolates during the COVID-19 Pandemic: Findings from the "EPIRADIOCLINF" Project.

Agodi A, Montineri A, Manuele R, Noto P, Carpinteri G, Castiglione G Antibiotics (Basel). 2023; 12(10).

PMID: 37887252 PMC: 10603994. DOI: 10.3390/antibiotics12101551.

Preventing Multidrug-Resistant Bacterial Transmission in the Intensive Care Unit with a Comprehensive Approach: A Policymaking Manual.

Schinas G, Polyzou E, Spernovasilis N, Gogos C, Dimopoulos G, Akinosoglou K Antibiotics (Basel). 2023; 12(8).

PMID: 37627675 PMC: 10451180. DOI: 10.3390/antibiotics12081255.

How Does Hospital Microbiota Contribute to Healthcare-Associated Infections?.

Cruz-Lopez F, Martinez-Melendez A, Garza-Gonzalez E Microorganisms. 2023; 11(1).

PMID: 36677484 PMC: 9867428. DOI: 10.3390/microorganisms11010192.

How does Quorum Sensing of Intestinal Bacteria Affect Our Health and Mental Status?.

Dicks L Microorganisms. 2022; 10(10).

PMID: 36296244 PMC: 9611604. DOI: 10.3390/microorganisms10101969.

References

Langer M, Carretto E, Haeusler E . Infection control in ICU: back (forward) to surveillance samples?. Intensive Care Med. 2001; 27(10):1561-3. DOI: 10.1007/s001340101069. View

Struelens M . Consensus guidelines for appropriate use and evaluation of microbial epidemiologic typing systems. Clin Microbiol Infect. 1996; 2(1):2-11. DOI: 10.1111/j.1469-0691.1996.tb00193.x. View

Jung R, Fish D, Obritsch M, MacLaren R . Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital. J Hosp Infect. 2004; 57(2):105-11. DOI: 10.1016/j.jhin.2004.03.001. View

Bertrand X, Thouverez M, Talon D, Boillot A, Capellier G, Floriot C . Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units. Intensive Care Med. 2001; 27(8):1263-8. DOI: 10.1007/s001340100979. View

Vincent J, Bihari D, Suter P, Bruining H, White J, Wolff M . The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA. 1995; 274(8):639-44. View

Tenover F, Arbeit R, Goering R, Mickelsen P, Murray B, Persing D . Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995; 33(9):2233-9. PMC: 228385. DOI: 10.1128/jcm.33.9.2233-2239.1995. View

Glupczynski Y, Delmee M, Goossens H, Struelens M . Distribution and prevalence of antimicrobial resistance among gram-negative isolates in intensive care units (ICU) in Belgian hospitals between 1996 and 1999. Acta Clin Belg. 2002; 56(5):297-306. DOI: 10.1179/acb.2001.044. View

Trautmann M, Lepper P, Haller M . Ecology of Pseudomonas aeruginosa in the intensive care unit and the evolving role of water outlets as a reservoir of the organism. Am J Infect Control. 2005; 33(5 Suppl 1):S41-9. DOI: 10.1016/j.ajic.2005.03.006. View

Mikolajczyk R, Sagel U, Bornemann R, Kramer A, Kretzschmar M . A statistical method for estimating the proportion of cases resulting from cross-transmission of multi-resistant pathogens in an intensive care unit. J Hosp Infect. 2006; 65(2):149-55. DOI: 10.1016/j.jhin.2006.10.005. View

10.

Weist K, Pollege K, Schulz I, Ruden H, Gastmeier P . How many nosocomial infections are associated with cross-transmission? A prospective cohort study in a surgical intensive care unit. Infect Control Hosp Epidemiol. 2002; 23(3):127-32. DOI: 10.1086/502021. View

11.

. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004; 32(8):470-85. DOI: 10.1016/S0196655304005425. View

12.

Aloush V, Navon-Venezia S, Seigman-Igra Y, Cabili S, Carmeli Y . Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother. 2005; 50(1):43-8. PMC: 1346794. DOI: 10.1128/AAC.50.1.43-48.2006. View

13.

Grundmann H, Barwolff S, Tami A, Behnke M, Schwab F, Geffers C . How many infections are caused by patient-to-patient transmission in intensive care units?. Crit Care Med. 2005; 33(5):946-51. DOI: 10.1097/01.ccm.0000163223.26234.56. View

14.

Deplano A, Denis O, Poirel L, Hocquet D, Nonhoff C, Byl B . Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J Clin Microbiol. 2005; 43(3):1198-204. PMC: 1081292. DOI: 10.1128/JCM.43.3.1198-1204.2005. View

15.

Meyer E, Schwab F, Jonas D, Rueden H, Gastmeier P, Daschner F . Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units. Intensive Care Med. 2004; 30(6):1089-96. DOI: 10.1007/s00134-004-2266-9. View

16.

Wenzel R, Thompson R, Landry S, Russell B, Miller P, Ponce de Leon S . Hospital-acquired infections in intensive care unit patients: an overview with emphasis on epidemics. Infect Control. 1983; 4(5):371-5. DOI: 10.1017/s0195941700059774. View

17.

Horan T, Emori T . Definitions of key terms used in the NNIS System. Am J Infect Control. 1997; 25(2):112-6. DOI: 10.1016/s0196-6553(97)90037-7. View

18.

Rello J, Ollendorf D, Oster G, Vera-Llonch M, Bellm L, Redman R . Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002; 122(6):2115-21. DOI: 10.1378/chest.122.6.2115. View

19.

Tenover F, Arbeit R, Goering R . How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. Molecular Typing Working Group of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol. 1997; 18(6):426-39. DOI: 10.1086/647644. View

20.

Agodi A . [Systems of epidemiological typing of microorganisms responsible for hospital infections: use and evaluation]. Ann Ig. 2000; 12(4 Suppl 2):41-6. View